TESTA, IVANO
 Distribuzione geografica
Continente #
NA - Nord America 650
EU - Europa 359
AS - Asia 146
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.157
Nazione #
US - Stati Uniti d'America 649
IE - Irlanda 145
CN - Cina 79
TR - Turchia 58
DE - Germania 41
SE - Svezia 41
GB - Regno Unito 37
UA - Ucraina 34
FI - Finlandia 17
FR - Francia 15
IT - Italia 12
BE - Belgio 10
SG - Singapore 6
IN - India 3
RU - Federazione Russa 3
AT - Austria 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ES - Italia 1
EU - Europa 1
MX - Messico 1
NZ - Nuova Zelanda 1
Totale 1.157
Città #
Chandler 156
Dublin 145
Jacksonville 139
Ann Arbor 57
New York 36
Boardman 32
Izmir 30
San Mateo 30
Wilmington 30
Nanjing 24
Lawrence 18
Princeton 18
Nanchang 11
Brussels 10
Woodbridge 10
Shenyang 8
Seattle 7
Verona 6
Des Moines 5
Düsseldorf 5
Falls Church 5
Los Angeles 5
Philadelphia 5
Zhengzhou 5
Kunming 4
Milan 4
Singapore 4
Tianjin 4
Hebei 3
Jinan 3
Ashburn 2
Auburn Hills 2
Beijing 2
Changsha 2
Jiaxing 2
Ningbo 2
Shanghai 2
Washington 2
Brno 1
Chicago 1
Fuzhou 1
Guangzhou 1
Hangzhou 1
Houston 1
Lanzhou 1
London 1
Lower Hutt 1
Madrid 1
Mexico City 1
Phoenix 1
Rome 1
Taizhou 1
Tallinn 1
Vienna 1
Totale 851
Nome #
Vitamin E intake reduces plasminogen activator inhibitor type 1 in T2DM patients 86
Fibronectin and lipoprotein(a) are inversely related to plasminogen activator inhibitor type-1 levels in NID diabetic patients without complications 84
Mitochondrial DNA backgrounds might modulate diabetes complications rather than T2DM as a whole. 84
Decreased insulin receptor but normal glucose metabolism in Duchenne muscolar dystrophy 82
In the Light of the Metabolic Memory Theory, Should Not All Aged People with Dysglycemia Be Treated? 75
Chronic renal impairment and DDAH2-1151 A/C polymorphism determine ADMA levels in type 2 diabetic subjects. 71
Glycosylated hemoglobin and fructosamines: does their determination really reflect the glycemic control in diabetic patients? 68
The Pro/Pro genotype of the p53 codon 72 polymorphism modulates PAI-1 plasma levels in ageing 67
A significant relationship between plasminogen activator inhibitor type-1 and lipoprotein(a) in non-insulin-dependent diabetes mellitus without complications 62
The METABOLIC Study: multidimensional assessment of health and functional status in older patients with type 2 diabetes taking oral antidiabetic treatment 61
Asymptomatic Helicobacter pylori Infection Increases Asymmetric Dimethylarginine Levels in Healthy Subjects 60
Pioglitazone Randomised Italian Study on Metabolic Syndrome (PRISMA): effect of pioglitazone with metformin on HDL-C levels in Type 2 diabetic patients 58
Tissue-specific antibobies against the fibroblast insulin receptor in a patient with lupus nephritis and hypoglycemia 57
Metformin treatment in elderly type II diabetic patients 54
Erytrocyte insulin receptors in non insulin dependent diabetes mellitus 52
Age-dependent changes of serum oxygen radical scavenger capacity and haemoglobin glycosylation in non-insulin-dependent diabetic patients 50
One- and two-compartment minimal models detect similar alterations of glucose metabolism indexes in hypertension 49
Visual and Hearing Impairment Are Associated With Delirium in Hospitalized Patients: Results of a Multisite Prevalence Study 39
Totale 1.159
Categoria #
all - tutte 4.172
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.172


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020150 36 1 20 3 1 18 29 1 19 3 1 18
2020/2021156 5 18 1 20 17 5 23 0 19 9 35 4
2021/2022114 9 15 16 9 9 2 5 9 6 5 7 22
2022/2023420 25 35 5 61 36 46 0 20 177 2 9 4
2023/202485 10 6 2 14 6 38 0 1 0 4 2 2
2024/20255 5 0 0 0 0 0 0 0 0 0 0 0
Totale 1.159